AVTX

AVTX

USD

Avalo Therapeutics Inc. Common Stock

$16.090-0.270 (-1.650%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$16.360

Máximo

$16.900

Mínimo

$15.810

Volumen

0.16M

Fundamentos de la Empresa

Capitalización de Mercado

286.4M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.35M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $3.39Actual $16.090Máximo $19.41

Noticias Relacionadas

GlobeNewswire

Avalo Therapeutics to Participate in Upcoming Investor Conferences

WAYNE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory

Ver más
Avalo Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire

Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa

WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory

Ver más
Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa